Correction of a Genetic Disease in Mouse via Use of CRISPR-Cas9

被引:559
|
作者
Wu, Yuxuan [1 ]
Liang, Dan [1 ,2 ]
Wang, Yinghua [1 ,2 ]
Bai, Meizhu [1 ,3 ]
Tang, Wei [4 ]
Bao, Shiming [5 ]
Yan, Zhiqiang [5 ]
Li, Dangsheng [6 ]
Li, Jinsong [1 ,3 ]
机构
[1] Chinese Acad Sci, Shanghai Key Lab Mol Androl, Grp Epigenet Reprogramming,Shanghai Inst Biol Sci, State Key Lab Cell Biol,Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China
[2] Univ Chinese Acad Sci, Beijing 100049, Peoples R China
[3] Shanghai Tech Univ, Sch Life Sci & Technol, Shanghai 200031, Peoples R China
[4] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Anim Core Facil, Shanghai 200031, Peoples R China
[5] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Lab Anim Ctr, Shanghai 201615, Peoples R China
[6] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Informat Ctr Life Sci, Shanghai 200031, Peoples R China
基金
中国国家自然科学基金;
关键词
ONE-STEP GENERATION; CAS9; NUCLEASE; HUMAN-CELLS; GENOME; SYSTEM; MICE; SPECIFICITY; MUTATIONS; ELEGANS;
D O I
10.1016/j.stem.2013.10.016
中图分类号
Q813 [细胞工程];
学科分类号
摘要
The CRISPR-Cas9 system has been employed to generate mutant alleles in a range of different organisms. However, so far there have not been reports of use of this system for efficient correction of a genetic disease. Here we show that mice with a dominant mutation in Crygc gene that causes cataracts could be rescued by coinjection into zygotes of Cas9 mRNA and a single-guide RNA (sgRNA) targeting the mutant allele. Correction occurred via homology-directed repair (HDR) based on an exogenously supplied oligonucleotide or the endogenous WT allele, with only rare evidence of off-target modifications. The resulting mice were fertile and able to transmit the corrected allele to their progeny. Thus, our study provides proof of principle for use of the CRISPR-Cas9 system to correct genetic disease.
引用
收藏
页码:659 / 662
页数:4
相关论文
共 50 条
  • [2] Genomic correction of Pompe disease knock-in mouse myoblasts via CRISPR-Cas9 homology-directed repair
    Sandfeld, Emilie K.
    Huang, Jeffrey Y.
    Kan, Shih-Hsin
    Wang, Raymond Y.
    MOLECULAR GENETICS AND METABOLISM, 2020, 129 (02) : S143 - S143
  • [3] Mouse Genome Engineering via CRISPR-Cas9 for Study of Immune Function
    Pelletier, Stephane
    Gingras, Sebastien
    Green, Douglas R.
    IMMUNITY, 2015, 42 (01) : 18 - 27
  • [4] CRISPR-Cas9 Applications in Cardiovascular Disease
    Khouzam, John Paul S.
    Tivakaran, Vijai S.
    CURRENT PROBLEMS IN CARDIOLOGY, 2021, 46 (03)
  • [5] Application of CRISPR-Cas9 in eye disease
    Wu, Wenyi
    Tang, Luosheng
    D'Amore, Patricia A.
    Lei, Hetian
    EXPERIMENTAL EYE RESEARCH, 2017, 161 : 116 - 123
  • [6] GENETIC THERAPIES Correcting genetic defects with CRISPR-Cas9
    Lokody, Isabel
    NATURE REVIEWS GENETICS, 2014, 15 (02) : 63 - 63
  • [7] Harnessing CRISPR-Cas9 immunity for genetic engineering
    Charpentier, Emmanuelle
    Marraffini, Luciano A.
    CURRENT OPINION IN MICROBIOLOGY, 2014, 19 : 114 - 119
  • [8] Chromosome drives via CRISPR-Cas9 in yeast
    Hui Xu
    Mingzhe Han
    Shiyi Zhou
    Bing-Zhi Li
    Yi Wu
    Ying-Jin Yuan
    Nature Communications, 11
  • [9] Chromosome drives via CRISPR-Cas9 in yeast
    Xu, Hui
    Han, Mingzhe
    Zhou, Shiyi
    Li, Bing-Zhi
    Wu, Yi
    Yuan, Ying-Jin
    NATURE COMMUNICATIONS, 2020, 11 (01)
  • [10] Scientists Journey Into Genomes Via CRISPR-Cas9
    Ricks, Delthia
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2015, 107 (11):